J Prev Med Public Health.  2004 Nov;37(4):353-358.

Cost-Utility Analysis of the Cochlear Implant

Affiliations
  • 1Graduate School of Public Health, Yonsei University, Korea.
  • 2Institute for Health Services Research, Yonsei University, Korea.
  • 3Department. of otolaryngology, College of Medicine, Yonsei University, Korea.
  • 4Department. of Preventive Medicine, College of Medicine, Yonsei University, Korea.
  • 5National Cancer Center, Korea. ecpark@ncc.re.kr

Abstract


OBJECTIVE
To determine the quality of life and cost consequences for deaf adults who received a cochlear implant. METHODS: The data from 11 patients, post-lingual deaf adults who received cochlear implants from 1990 to 2002, underwent cost-utility analysis. The average age of the participants was 49.6 years. The main outcomes were direct cost per quality-adjusted life-year (QALY) using the visual analog scale (VAS), health utility index (HUI), EuroQol (EQ-5D), and quality well-being (QWB), with costs and utilities being discounted 3% annually. RESULTS: Recipients had an average of 5.6 years of implant use. Mean VAS scores increased by 0.33, from 0.27 before implantation to 0.60 at survey. HUI scores increased by 0.36, from 0.29 to 0.65, EQ-5D scores increased by 0.26, from 0.52 to 0.78, and QWB scores increased by 0.16, from 0.45 to 0.61. Discounted direct costs were $22, 320, yielding $19, 223/QALY using VAS, $17, 387/QALY using HUI, $24, 604/QALY using EQ-5D, and $40, 474/QALY using QWB. Cost-utility ratios using VAS, HUI, and EQ-5D were all below $25, 000 per QALY, except using QWB. CONCLUSION: Cochlear implants in post-lingual deaf adult have a positive effect on quality of life at reasonable direct costs and appear to produce a net saving to society.

Keyword

Cost-utility analysis; Cochlear implant; Qualityadjusted life-year

MeSH Terms

Adult
Cochlear Implants*
Cost-Benefit Analysis*
Humans
Quality of Life
Quality-Adjusted Life Years
Visual Analog Scale
Full Text Links
  • JPMPH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr